Webinar: Patient Enrollment in Oncology
Clinical Trials Challenges & Best Solutions
 

Patient enrollment has always been a challenge in clinical trials, in general and it is more so in oncology clinical trials. Oncology clinical trials take longer time than other therapeutic areas primarily due to delays in patient enrollment. In US, the adult participation in cancer clinical trials remains around 3% with even lower participation rates among ethnic, racial minorities and elderly people. Sponsors/CROs and sites increasingly struggle to reach enrollment targets due to a variety of reasons including nature of disease itself. However, understanding, analyzing these challenges & barriers in patient enrollment in oncology trials and addressing them with thoughtful, strategic, result-oriented plans & procedures is the key to success.

This webinar will cover
  • Understanding challenges around patient enrollment in oncology clinical trials
  • Key policies and procedures that sites can do to enhance enrollment in oncology CTs
  • Practical approaches for community engagement in oncology CTs
  
Date & Time
Date: 28th November 2012
Time: 2 PM US EST – 3 PM US EST

 

 
Who should participate?
Clinical Operational professionals in Medical / Healthcare / Pharmaceutical / Biotech /Medical device industries.
Limited Participants:
Maximum 50 only
Cost:
None
Email:
Send your information for registration to This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Speakers
  
Margo Michaels, MPH
Executive Director, ENACCT, USA
Adjunct Clinical Assistant Professor, Boston University School of Public Health

Nariman Nasser, CCRP,
Senior Director
Recruitment & Implementation Core
Clinical Research Services
Clinical & Translational Science Institute
University of California, San Francisco, USA
 
Facilitator
  

Ashok K. Ghone, Ph.D.
VP-Global Services, MakroCare, USA
 

Basic Requirement: From your own Desk (minimum requirement: Internet connection & Speaker / head set).

About MakroCare:

MakroCare is an international drug development and commercialization services firm that is dedicated to efficient, high-level performance in combination with unparalleled client satisfaction supporting from USA, Europe and Asia. MakroCare has 5 subsidiaries/divisions – Consulting, CRO, SMO, DDi and Commercialization. MakroCare has teams positioned worldwide in these divisions supporting product life cycle management, regulatory affairs, risk management, regulatory compliance, trial management (clinical, late phase), monitoring, biometrics (CDM, EDC, Biostat, SAS programming), Medical Writing (Regulatory, Clinical), QA audits, Drug safety / Pharmacovigilance, Site management, Patient Recruitment, Informatics (EDC, CTMS, IVRS), Commercialization, and Marketing/Sales.